Hyperhomocysteinemia in winter elite athletesl: A longitudinal study

Journal of Endocrinological Investigation

Volumn 30, Issue 5, 2007, Pages 367-375

  Borrione, P ^a,e   Pigozzi, F ^b   Massazza, G ^c   Schonhuber, H ^d   Viberti, G ^e   Paccotti, P ^a   Angeli, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF ROME FORO ITALICO   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Medical Board Italian Winter Sports Federation FISI   (Italy)

^e SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Cardio vascular risk factor; Elite athletes; Exercise; Homocysteine; Hyperhomocysteinemia

Indexed keywords

CREATINE KINASE; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATHLETE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; LONGITUDINAL STUDY; MALE; MEDICAL ASSESSMENT; MORBIDITY; MORTALITY; MUSCLE FUNCTION; NORMAL HUMAN; PREVALENCE; REFERENCE VALUE; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TRAINING; WINTER SPORT; BLOOD; CARDIOVASCULAR DISEASE; EXERCISE; GENETICS; GENOTYPE; RISK FACTOR; SEASON; SEX RATIO; SPORT; STATISTICS;

ADULT; CARDIOVASCULAR DISEASES; EXERTION; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LONGITUDINAL STUDIES; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PREVALENCE; RISK FACTORS; SEASONS; SEX DISTRIBUTION; SPORTS;

EID: 34447628661     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346312     Document Type: Article

References (33)

1. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993, 39: 1764-79.
2. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992, 12: 279-98.
3. Kluijtmans LA, Young IS, Boreham CA, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 2003, 101: 2483-8.
4. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270: 2693-8.
5. Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for endothelial dysfunction in humans. Circulation 1997, 96: 2542-4.
6. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994, 91: 6369-73.
7. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969, 56: 111-28.
8. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998, 338: 1042-50.
9. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992, 268: 877-81.
10. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288: 2015-22.
11. Wald IDS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325: 1202.
12. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997, 90: 1 -11.
13. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131: 363-75.
14. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989, 114: 473-501.
15. Einecke D. The athletic career, unfortunately not really atypical. From model athlete to infarct candidate. MMW Fortschr Med 2002, 144: 6-7.
16. Pihl E, Jurimae T. Relationships between body weight change and cardiovascular disease risk factors in male former athletes. Int J Obes Relat Metab Disord 2001, 25: 1057-62.
17. Pipe A. The adverse effects of elite competition on health and well-being. Can J Appl Physiol 2001, 26 Suppl: S192-201.
18. De Cree C, Malinow MR, van Kranenburg GP, Geurten PG, Longford NT, Keizer HA. Influence of exercise and menstrual cycle phase on plasma homocyst(e)ine levels in young women--a prospective study. Scand J Med Sci Sports 1999, 9: 272-8.
19. De Cree C, Whiting PH, Cole H. Interactions between homocyst(e)ine and nitric oxide during acute submaximal exercise in adult males. Int J Sports Med 2000, 21: 256-62.
20. Herrmann M, Schorr H, Obeid R, et al. Homocysteine increases during endurance exercise. Clin Chem Lab Med 2003, 41: 1518-24.
21. Wright M, Francis K, Cornwell P. Effect of acute exercise on plasma homocysteine. J Sports Med Phys Fitness 1998, 38: 262-5.
22. Herrmann M, Wilkinson J, Schorr H, et al. Comparison of the influence of volume-oriented training and high-intensity interval training on serum homocysteine and its cofactors in young, healthy swimmers. Clin Chem Lab Med 2003, 41: 1525-31.
23. 12. Ann Nutr Metab 2003, 47: 114-8.
24. Okura T, Rankinen T, Lussier-Cacan S, et al. Effect of regular aerobic exercise on plasma homocysteine concentrations: The HERITAGE family study. Med Sci Sports Exerc 2004, 36 Suppl: S188-9.
25. Terzolo M, Allasino B, Bosio S, et al. Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004, 89: 3745-51.
26. Hayward R, Ruangthai R, Karnilaw P, et al. Attenuation of homocysteine-induced endothelial dysfunction by exercise training. Pathophysiology 2003, 9: 207-14.
27. Randeva HS, Lewandowski KC, Drzewoski J, et al. Exercise decreases plasma total homocysteine in overweight young women with poiycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 4496-501.
28. Vincent KR, Braith RW, Bottiglieri T, Vincent HK, Lowenthal DT. Homocysteine and lipoprotein levels following resistance training in older adults. Prev Cardiol 2003, 6: 197-203.
29. Graham MR, Grace FM, Boobier W, et al. Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse. Br J Sports Med 2006, 40: 644-8.
30. Grace FM, Davies B. Raised concentrations of C reactive protein in anabolic steroid using bodybuilders. Br J Sports Med 2004, 38: 97-8.
31. Deligiannis A, Bjornstad H, Carre F, et al. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 2006, 13: 687-94.
32. Sacchi E, Tagliabue L, Duca F, Mannucci PM. High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost 1997, 78: 963-4.
33. den Heijer M, Brower IA, Bos GM, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healty volunteers. Arterioscler Thromb Vasc Biol 1998, 18: 356-61.